Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis
J Invest Dermatol, 2022.
Douroudis K, Ramessur R, Barbosa IA, Baudry D, Duckworth M, Angit C, Capon F, Chung R, Curtis CJ, Di Meglio P, Goulding JMR, Griffiths CEM, Lee SH, Mahil SK, Parslew R, Reynolds NJ, Shipman AR, Warren RB, Yiu ZZN, Simpson MA, Barker JN, Dand N, Smith CH; BADBIR; BSTOP Study Groups.
Read publication: J Invest Dermatol
Related
Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe pso...
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab a...
Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the Br...
0 Comments